Tenet Healthcare Corporation (THC)
NYSE: THC · IEX Real-Time Price · USD
97.51
-0.75 (-0.76%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 101.12, with a low estimate of 81 and a high estimate of 126. The average target predicts an increase of 3.70% from the current stock price of 97.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for THC stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Buy | 6 | 6 | 6 | 6 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $100 → $126 | Strong Buy | Maintains | $100 → $126 | +29.22% | Apr 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $104 | Buy | Reiterates | $104 | +6.66% | Apr 10, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $105 → $115 | Buy | Maintains | $105 → $115 | +17.94% | Mar 28, 2024 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $122 | Hold → Buy | Upgrades | $122 | +25.12% | Mar 27, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +12.81% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
20.57B
from 20.56B
Increased by 0.02%
Revenue Next Year
21.48B
from 20.57B
Increased by 4.43%
EPS This Year
6.09
from 5.71
Increased by 6.58%
EPS Next Year
7.13
from 6.09
Increased by 17.21%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.7B | 23.9B | 24.7B | 27.0B | 28.8B |
| Avg | 20.6B | 21.5B | 22.6B | 26.0B | 27.7B |
| Low | 19.6B | 20.1B | 21.1B | 25.2B | 26.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.5% | 16.3% | 15.0% | 19.5% | 10.6% |
| Avg | 0.0% | 4.4% | 5.4% | 15.0% | 6.4% |
| Low | -4.8% | -2.5% | -1.6% | 11.5% | 3.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.00 | 8.93 | 10.43 | 9.48 | 10.74 |
| Avg | 6.09 | 7.13 | 8.51 | 9.12 | 10.33 |
| Low | 3.78 | 4.77 | 6.63 | 8.85 | 10.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.7% | 46.7% | 46.2% | 11.4% | 17.8% |
| Avg | 6.6% | 17.2% | 19.3% | 7.2% | 13.3% |
| Low | -33.8% | -21.6% | -7.0% | 4.0% | 9.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.